Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 4:03 AM
Ignite Modification Date:
2025-12-25 @ 4:03 AM
NCT ID:
NCT07007702
Brief Summary:
The goal of this prospective, open, monocentric study is to evaluate the clinical efficacy of a new preservative-free combination of trehalose, sodium hyaluronate and NAAGA in 30 patients with chronic dry eye disease and associated ocular surface inflammation.
The main question it aims to answer is:
\- To assess the improvement of conjunctival hyperemia as well as subjective symptoms in patients with moderate to severe dry eye.
Participants will be asked to use T2769 on a daily basis.
Study:
NCT07007702
Study Brief:
Protocol Section:
NCT07007702